R. Fogari et al., COMPARATIVE EFFECTS OF LISINOPRIL AND LOSARTAN ON INSULIN SENSITIVITYIN THE TREATMENT OF NON DIABETIC HYPERTENSIVE PATIENTS, British journal of clinical pharmacology, 46(5), 1998, pp. 467-471
Aims The aim of this study was to compare the effects of the ACE-inhib
itor lisinopril and the angiotensin II receptor antagonist losartan on
insulin sensitivity in the treatment of non diabetic hypertensives. M
ethods Twenty-five non diabetic subjects with mild to moderate hyperte
nsion, 11 females and 14 males, aged 44-63 years, after a 4-week wash-
out period on placebo, were randomized to receive lisinopril 20 mg onc
e daily or losartan 50 mg once daily for 6 weeks. Following another 4-
week wash-out period, patients were crossed to the alternative regimen
for further 5 weeks. At the end of the placebo and of the active trea
tment periods, blood pressure (BP) was measured (by standard mercury s
phygmomanometer, Korotkoff I and V) and insulin sensitivity was assess
ed by the euglycaemic hyperinsulinaemic clamp technique. Glucose infus
ion rate (GIR) during the last 30 min of clamp and total glucose requi
rement (TGR) were evaluated. Results Both lisinopril and losartan sign
ificantly reduced SBP (by a mean of 20.2 and 17.2 mmHg, respectively)
and DBP (by a mean of 15.2 and 12.3 mmHg, respectively), with no diffe
rence between the two treatments. GIR, used as an indicator of insulin
sensitivity, was significantly increased by lisinopril (+1.5 mg min(-
1) kg(-1), P<0.05 vs baseline) but not by losartan (+0.42 mg min(-1) k
ig(-1), NS), the difference between the two drugs being statistically
significant (P<0.05). TGR was increased by lisinopril (+7.3 g, P<0.05
vs baseline), whereas losartan did not significantly modify it (+1.9 g
, NS). Conclusions In conclusion, with all cautions due to an absence
in this study of a randomized placebo phase, our findings suggest that
lisinopril improved insulin sensitivity whereas losartan did not affe
ct it.